Identification of TUBB4A as a Prognostic Biomarker of Melanoma by Transcriptomic Data and <i>In Vitro</i> Experiments.
Journal Information
Full Title: Technol Cancer Res Treat
Abbreviation: Technol Cancer Res Treat
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."
"Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Changzhou Sci & Tech Program (Grant Nos. CJ20220156 and CJ20210166), the China Postdoctoral Science Foundation No. 72 General Fund (Grant No. 2022M720542), and the Science and Technology Development Fund of Nanjing Medical University (Grant No. NMUB20220195). Scientific Program of Jiangsu Commission of Health (Grant No. M2022051)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025